Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 51, Issue 3, 2001, Pages 650-659

  Hernando, Maria L ^a   Marks, Lawrence B ^a   Bentel, Gunilla C ^a   Zhou, Su Min ^a   Hollis, Donna ^a   Das, Shiva K ^a   Fan, Ming ^a   Munley, Michael T ^a   Shafman, Timothy D ^a   Anscher, Mitchell S ^a   Lind, Pehr A ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

3D treatment planning; Lung neoplasm; Modeling; Normal tissue complication probability; Radiation pneumonitis; Radiation toxicity

Indexed keywords

DOSIMETRY; PATIENT MONITORING; PLANNING; PULMONARY DISEASES; RADIATION; RADIOTHERAPY;

LUNG CANCER;

TOXICITY;

ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; DOSIMETRY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HISTOGRAM; HUMAN; LUNG CANCER; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION PNEUMONIA; SMOKING; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL; SMOKING;

EID: 0035501213     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01685-6     Document Type: Article

References (43)

1. Dose volume histogram and 3D treatment planning evaluation of patients with pneumonitis
2. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis
3. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
4. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients
5. The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer
6. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer
7. Risk factors of pneumonitis following chemoradiotherapy for lung cancer
8. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer
9. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: A randomized study
10. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy, and radiotherapy for locally advanced non-small-cell carcinoma of the lung
11. Effects of ongoing smoking on the development of radiation-induced pneumonitis in breast cancer and oesophagus cancer patients
12. Radiation-induced pulmonary injury: Symptomatic versus subclinical endpoints
13. Positioning and immobilization of patients undergoing radiation therapy for Hodgkin's disease
14. The equivalent tissue-air ratio method for making absorbed dose calculations in a heterogeneous medium
15. Treatment planning at the University of North Carolina at Chapel Hill
16. Virtual simulation: Initial clinical results
17. Experimental tests of corrections for tissue inhomogeneities in radiotherapy
18. High-dose, hyperfractionated, accelerated radiotherapy using a concurrent boost for the treatment of nonsmall cell lung cancer. Unusual toxicity and promising early results
19. 73.6 Gy and beyond: Hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer
20. Complication probability as assessed from dose-volume histograms
21. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method
22. Optimization of radiation therapy, IV: A dose-volume histogram reduction algorithm
23. Radiation-induced increase in hyaluronan, and fibronectin in bronchoalveolar lavage fluid from breast cancer patients is suppressed by smoking
24. Reversible alterations in immunoregulatory T cells in smoking: Analysis by monoclonal antibodies and flow cytometry
25. Influence of carboxyhemoglobin level on tumor growth, blood flow and radiation response in an experimental model
26. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer
27. Smoking: The influence of carboxyhemoglobin (HbCO) on tumor oxygenation and response to radiation
28. Phase I/IIa study of concurrent paclitaxel, and cisplatin with radiation therapy in locally advanced non-small cell lung cancer. Analysis of early and late pulmonary morbidity
29. Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer
30. Concurrent chemoradiation therapy with oral etoposide and Radiation Therapy Oncology Group Protocol 91-06
31. Radiation pneumonitis following combined modality therapy for lung cancer: Analysis of prognostic factors
32. The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC) - Analysis of a Radiation Therapy Oncology Group (RTOG) protocol
33. Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer
34. Deep inspiration breath-hold technique for lung tumors: The potential value of target immobilization and reduced lung density in dose escalation
35. Computerized design of target margins for treatment uncertainties in conformal radiotherapy
36. Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing
37. The simultaneous boost technique: The concept of relative normalized total dose
38. Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation
39. Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation
40. Modeling of normal tissue response to radiation: The critical volume model
41. Changes in plasma transforming growth factor B1 during radiotherapy: A predictor of radiation pneumonitis